A living WHO guideline on drugs for covid-19

A living WHO guideline on drugs for covid-19

Clinical question What is the role of drug interventions in the treatment of patients with covid-19?New recommendation The latest version of this WHO living guidance focuses on remdesivir, following the 15 October 2020 preprint publication of results from the WHO SOLIDARITY trial. It contains a weak...

Full description

Bibliographic Details
Main Authors: Rochwerg, B, Agoritsas, T, Lamontagne, FCC, Leo, Y-S, Macdonald, H, Agarwal, A, Zeng, L, Lytvyn, L, Appiah, JA, Amin, W, Arabi, Y, Blumberg, L, Burhan, E, Bausch, F, Calfee, CS, Cao, B, Cecconi, M, Chanda, D, Cooke, G, Dunning, J, Du, B, Geduld, H, Gee, P, Hashimi, M, Hui, DS, Kabra, S, Kanda, S, Kawano-Dourado, L, Kim, Y-J, Kissoon, N, Kwizera, A, Laake, JH, Machado, FR, Mahaka, I, Manai, H, Mino, G, Nsutebu, E, Pshenichnaya, N, Qadir, N, Sabzwari, S, Sarin, R, Sharland, M, Shen, Y, Ranganathan, SS, Souza, J, Ugarte, S, Venkatapuam, S, Dat, VQ, Vuyiseka, D, Wuewickrama, A
Format: Journal article
Language:English
Published: BMJ Publishing Group 2020

Similar Items